Welcome To The PAINWeek 2026 Presentation Proposal Submission Site

Proposal Guidelines

All PAINWeek presentation proposals must demonstrate strict adherence to evidence-based medicine and regulatory compliance. Proposals must be supported exclusively by peer-reviewed research published in recognized medical journals, with preference given to systematic reviews, meta-analyses, and established clinical practice guidelines. All pharmaceutical interventions, medical devices, and therapeutic procedures discussed must have current FDA approval for the specific indications presented. Off-label use must be clearly disclosed with appropriate safety warnings and substantial clinical evidence. Proposals featuring anecdotal evidence, unpublished studies, theoretical frameworks without clinical validation, unregulated supplements, or alternative medicine approaches lacking rigorous scientific support will be automatically rejected.

PAINWeek evaluates evidence quality, regulatory compliance, and clinical relevance. All presentations must align with established clinical practice guidelines, provide balanced risk-benefit analyses, emphasize patient safety, and use validated outcome measures. Presenters are held accountable for maintaining scientific accuracy and regulatory compliance throughout their presentations, with PAINWeek and the accredited provider reserving the right to monitor content and require modifications. This commitment ensures that all PAINWeek educational content advances evidence-based pain management through scientifically validated, FDA-approved interventions that meaningfully contribute to improved patient outcomes.

Presentation Details

Presentation spots at the PAINWeek 2026 meeting will be 50 minutes. Please keep this in mind as you develop and complete your proposal outline. If you are submitting a proposal that would require more than 50 minutes, please indicate this in your proposal decsription.

Completion of Steps

ALL submission steps MUST be completed in a proposal to be reviewed. If a submission has incomplete items, it will not be reviewed for the meeting.

Disclosures

PAINWeek requires each submitter and any/all co-presenters listed, to complete a disclosure during the submission process. At the time of completion, we will review for any conflicts of interest or relations with ineligible companies as it relates to the topic(s) you wish to present. Should your proposal be of interest and there is an issue with your disclosure, we will reach out to you directly.

Deadlines

All proposals MUST be submitted by 11:59p ET, Sunday, January 25, 2026. All submitters will be notified of their presentation status no later than April 3, 2026.

Your expertise deserves the premier platform that PAINWeek provides. These guidelines are designed to help you craft a compelling proposal that resonates with our diverse audience of pain management professionals and positions you as a thought leader in the field.